Suberoylanilide hydroxamic acid (Zolinza/vorinostat) sensitizes TRAIL-resistant breast cancer cells orthotopically implanted in BALB/c nude mice
Shankar, S., Davis, R., Singh, K. P., Kurzrock, R., Ross, D. D., Srivastava, R. K.Volume:
8
Language:
english
Journal:
Molecular Cancer Therapeutics
DOI:
10.1158/1535-7163.MCT-08-1004
Date:
June, 2009
File:
PDF, 774 KB
english, 2009